Figure 3.
Summary of patients treated with genomic‐guided therapy and progression‐free survival. One patient with BRCA2 mutation and metastatic pancreatic cancer recently started irinotecan and cisplatin and was not evaluable.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.